R.F. Murphy

965 total citations
26 papers, 796 citations indexed

About

R.F. Murphy is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cell Biology. According to data from OpenAlex, R.F. Murphy has authored 26 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Cell Biology. Recurrent topics in R.F. Murphy's work include Cellular transport and secretion (6 papers), Neuropeptides and Animal Physiology (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). R.F. Murphy is often cited by papers focused on Cellular transport and secretion (6 papers), Neuropeptides and Animal Physiology (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). R.F. Murphy collaborates with scholars based in United States, United Kingdom and Malaysia. R.F. Murphy's co-authors include Elizabeth W. Jones, Robert A. Preston, David M. Sipe, J. NELSON, Sándor Lovas, Géza Tóth, Brian Walker, Chris Shaw, DG Poplack and Frank M. Balis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Cell Biology and JNCI Journal of the National Cancer Institute.

In The Last Decade

R.F. Murphy

26 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.F. Murphy United States 12 513 217 95 89 89 26 796
Shad R. Eubanks United States 9 1.0k 2.0× 198 0.9× 148 1.6× 146 1.6× 55 0.6× 10 1.5k
Satyan Sharma Germany 15 505 1.0× 163 0.8× 54 0.6× 76 0.9× 53 0.6× 23 681
Gregg E. Davies United States 12 658 1.3× 208 1.0× 76 0.8× 53 0.6× 35 0.4× 26 1.2k
Kenton L. Longenecker United States 19 664 1.3× 125 0.6× 76 0.8× 153 1.7× 49 0.6× 32 1.1k
Xing‐Mai Jiang Australia 13 580 1.1× 215 1.0× 51 0.5× 102 1.1× 73 0.8× 21 1.1k
Wiebke Stahlschmidt Germany 7 622 1.2× 431 2.0× 75 0.8× 41 0.5× 48 0.5× 8 844
Colleen B. Brewer United States 9 460 0.9× 261 1.2× 48 0.5× 51 0.6× 91 1.0× 11 684
Kumiko Ishii Japan 20 799 1.6× 203 0.9× 65 0.7× 72 0.8× 67 0.8× 44 1.2k
Xiao‐Xia Shao China 20 759 1.5× 98 0.5× 86 0.9× 70 0.8× 68 0.8× 84 1.4k
Elisabeth P.C. Kilsdonk Netherlands 7 906 1.8× 297 1.4× 80 0.8× 122 1.4× 56 0.6× 11 1.4k

Countries citing papers authored by R.F. Murphy

Since Specialization
Citations

This map shows the geographic impact of R.F. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.F. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.F. Murphy more than expected).

Fields of papers citing papers by R.F. Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.F. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.F. Murphy. The network helps show where R.F. Murphy may publish in the future.

Co-authorship network of co-authors of R.F. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of R.F. Murphy. A scholar is included among the top collaborators of R.F. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.F. Murphy. R.F. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stone, Patrick, R.F. Murphy, Hosam E. Matar, & Muhammad Qutayba Almerie. (2008). Measuring the individual quality of life of patients with prostate cancer. Prostate Cancer and Prostatic Diseases. 11(4). 390–396. 15 indexed citations
2.
Stone, Patrick, R.F. Murphy, Hosam E. Matar, & Muhammad Qutayba Almerie. (2008). Quality of life in patients with prostate cancer: development and application of a hybrid assessment method. Prostate Cancer and Prostatic Diseases. 12(1). 72–77. 1 indexed citations
3.
Tóth, Géza, R.F. Murphy, & Sándor Lovas. (2001). Stabilization of local structures by π–CH and aromatic–backbone amide interactions involving prolyl and aromatic residues. Protein Engineering Design and Selection. 14(8). 543–547. 57 indexed citations
4.
Adamson, Peter C., Henry C. Pitot, Frank M. Balis, et al.. (1993). Variability in the Oral Bioavailability of All-trans-Retinoic Acid. JNCI Journal of the National Cancer Institute. 85(12). 993–996. 49 indexed citations
5.
NELSON, J., et al.. (1991). Bombesin stimulates proliferation of human breast cancer cells in culture. British Journal of Cancer. 63(6). 933–936. 62 indexed citations
6.
Roederer, Mario, et al.. (1990). Endosomes can undergo an ATP-dependent density increase in the absence of dense lysosomes.. PubMed. 51(2). 229–34. 23 indexed citations
7.
Haugen, S. E., A. Douglas, Bernt Rønning, et al.. (1989). Bioactivity Studies on New Gastrin Analogues. Scandinavian Journal of Gastroenterology. 24(5). 577–580. 1 indexed citations
8.
NELSON, J., et al.. (1989). Synthesis of somatostatin by breast cancer cells and their inhibition by exogenous somatostatin and sandostatin. British Journal of Cancer. 59(5). 739–742. 35 indexed citations
9.
Falloon, Judith, Frank M. Balis, R.F. Murphy, et al.. (1989). Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. International Journal of Gynecology & Obstetrics. 28(4). 394–394. 17 indexed citations
10.
Johnston, C.F., et al.. (1988). Pancreastatin-immunoreactivity (PST-IR) in human pancreas and adrenal gland. Regulatory Peptides. 22(4). 419–419. 1 indexed citations
11.
Murphy, R.F., et al.. (1988). A chloroquine-resistant Swiss 3T3 cell line with a defect in late endocytic acidification. The Journal of Cell Biology. 106(2). 269–277. 37 indexed citations
12.
Allen, Justin, et al.. (1987). Identification and characterisation of GRP-like immunoreactivity in bovine mesenteric lymphatics. Regulatory Peptides. 19(1-2). 109–109. 2 indexed citations
13.
Douglas, A., et al.. (1987). Preparation and biological activity of N-tBOC-Trp-Leu-β-Ala: A C-terminal gastrin analogue. Regulatory Peptides. 18(5-6). 367–367. 1 indexed citations
14.
Preston, Robert A., R.F. Murphy, & Elizabeth W. Jones. (1987). Apparent endocytosis of fluorescein isothiocyanate-conjugated dextran by Saccharomyces cerevisiae reflects uptake of low molecular weight impurities, not dextran.. The Journal of Cell Biology. 105(5). 1981–1987. 67 indexed citations
15.
Johnston, C.F., et al.. (1987). C-terminal pancreastatin immunoreactivity in the pancreas of several mammals. Regulatory Peptides. 18(5-6). 379–379. 1 indexed citations
16.
Fairweather, I., et al.. (1987). Immunocytochemical demonstration of vertebrate neuropeptides in the rat tapeworm,. Regulatory Peptides. 18(5-6). 372–372. 1 indexed citations
17.
Johnston, C.F., et al.. (1986). The presence of peptide Histidine-Isoleucine-like immunoreactivity in the rat retina. Regulatory Peptides. 15(2). 176–176. 3 indexed citations
18.
Murphy, R.F.. (1985). Analysis and isolation of endocytic vesicles by flow cytometry and sorting: demonstration of three kinetically distinct compartments involved in fluid-phase endocytosis.. Proceedings of the National Academy of Sciences. 82(24). 8523–8526. 53 indexed citations
19.
Jonung, T., et al.. (1984). Effect of Extragastric Vagotomy on Pancreatic Polypeptide in Dogs. Digestion. 29(2). 103–106. 6 indexed citations
20.
Balasubramaniam, A., et al.. (1983). Synthesis of PYY for production of antibodies. Regulatory Peptides. 7(3). 275–275. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026